Evidence map›Paper›PMID 37880574›Full record

ArticleBMC infectious diseases2023

Diagnostic delay, treatment duration and outcomes since the implementation of integrated model of tuberculosis control and their associated factors in a county in East China.

Yuanxiang Xie, Ting Ting Shum, Zhenming Tian, Chuanheng Lin, Lingyuan Chen, Bin Chen, Dajiang Huang, Lei Zhu, Guanyang Zou

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. The Incidence, Risk Factors, and Predictive Model of Obstructive Disease in Post-Tuberculosis Patients.International journal of chronic obstructive pulmonary disease · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yuanxiang Xie *School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, China.
Ting Ting ShumDepartment of Social Anthropology, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.
Zhenming TianSchool of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, China.
Chuanheng LinCenter for Public Health, Longgang County, Wenzhou, Zhejiang Province, China.
Lingyuan ChenCenter for Disease Prevention and Control, Cangnan County, Wenzhou, Zhejiang Province, China.
Bin ChenZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Dajiang HuangCenter for Public Health, Longgang County, Wenzhou, Zhejiang Province, China.
Lei ZhuSchool of Postgraduate Studies, Guangzhou University of Chinese Medicine, Guangzhou, China. zhulei@gzucm.edu.cn.
Guanyang Zou *School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, China. Gzou2023@outlook.com.
Guangzhou University of Chinese Medicine · CNZhejiang Center for Disease Control and Prevention · CNUniversity of Edinburgh · GB

Funding

National Social Science Foundation of China Grant Number 20&ZD122Zhejiang Provincial Science and Public Welfare Project LGF19H260004
6 · The paper itself

Abstract

objectiveThis study assesses the diagnostic delay, treatment duration and treatment outcomes of tuberculosis (TB) patients since the implementation of the integrated model of TB control in a county in eastern China. It further identifies factors associated with diagnostic delay and treatment duration in the integrated model.

methodsWe collected data through the Chinese Tuberculosis Information Management System (TBIMS) for Cangnan County in Zhejiang Province. Chi-square and Mann-Whitney tests were adopted to identify factors associated with duration of treatment and treatment delay for TB patients within the integrated model. Multiple regression analysis was subsequently performed to confirm the identified factors.

resultsIn the integrated model from 2012 to 2018, the median health system delay was maintained at 1 day, and the median patient delay decreased from 14 to 9 days and the median total delay decreased from 15 to 11 days. In addition, the proportion of patients who experienced patient delay > 14 days and total delay > 28 days decreased from 49% to 35% and from 32% to 29% respectively. However, the proportion of patients who had health system delay > 14 days increased from 0.2% to 13% from 2012 to 2018. The median treatment duration increased from 199 to 366 days and the number of TB patients lost to follow-up showed an overall upward trend from 2012 to 2018. The multivariable regression analysis indicated that migrant TB patients and TB patients initially diagnosed in hospitals at the prefectural level and above tended to experience total delay > 28 days (p < 0.001). Linear regression analysis confirmed that new TB patients>60 years tended to have longer treatment duration (p < 0.05).

conclusionsWhile our study may suggest the potential of the integrated model in early detection and diagnosis of TB, it also suggests the importance of strengthening supervision and management of designated hospitals to optimize the treatment duration and improve retention of patients in TB care. Enhancing health education for TB patients, especially amongst migrant patients, and training in TB identification and referral for non-TB doctors are also key for early TB detection and diagnosis in the integrated model.

Indexed as

Duration of TherapyTuberculosisChinaDelayed DiagnosisHospitalsHumansReferral and ConsultationChinaDiagnostic delayIntegrated modelTreatment durationTreatment outcomeTuberculosis control

Identifiers

PMID37880574
PMCPMC10601170
OpenAlexW4387933648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.